உலகளாவிய பிரச்சாரம் எதிராக கால் கை வலிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உலகளாவிய பிரச்சாரம் எதிராக கால் கை வலிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உலகளாவிய பிரச்சாரம் எதிராக கால் கை வலிப்பு Today - Breaking & Trending Today

Let's shine a light on epilepsy – Janet Mifsud

What connects this diverse group of persons: Julius Caesar, Fyodor Dostoevsky, the singer Prince, Susan Boyle and US Chief Justice John Roberts? They have all experienced one of the most misunderstood, maligned and stigmatising medical conditions – epilepsy.
Persons with epilepsy have been unfairly singled out, prosecuted and discriminated by various cultures and societies across the millennia. Persons with epilepsy have been and still are unjustly perceived as being possessed by magic or supernatural power, despite it being so common. It affects around one per cent of the population worldwide, across all ages.
This means that around 4,000 persons in Malta have epilepsy. One cannot stress enough that a person is not ‘epileptic’ or ‘suffers from epilepsy’, since such terms reinforce the stigmatisation. ....

Malta General , Palazzo Ferreria , Susan Boyle , Palazzo Castellania , Janet Mifsud , Justice John Roberts , Julius Caesar , Fyodor Dostoevsky , Office Of The Deputy , Global Campaign Against Epilepsy , University Of Malta , Ministry For Health , International League Against Epilepsy , Caritas Malta Epilepsy Association , Department Of Clinical Pharmacology , World Health Organisation , International Epilepsy Day , International Bureau For Epilepsy , Ministry For Social Justice , Ministry For The Inclusion , Ministry For , Justice John , Clinical Pharmacology , International Bureau , Epilepsy Day , Eiffel Tower ,

ONTOZRY™ (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults*

ONTOZRY™ (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults
January 29, 2021 12:20 ET
| Source:
Arvelle Therapeutics
Arvelle Therapeutics
Positive CHMP opinion is an important milestone for Arvelle Therapeutics and cenobamate
When approved, cenobamate will provide new hope in helping adult patients with uncontrolled focal epilepsy move closer to the goal of seizure reduction and seizure freedom
ZUG, Switzerland, Jan. 29, 2021 (GLOBE NEWSWIRE) Arvelle Therapeutics, an emerging biopharmaceutical company focused on bringing innovative treatments to patients suffering from central nervous system (CNS) disorders, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of cenobamate for the ....

United Kingdom , Mark Altmeyer , Juan Vergez , Engelj Ann Indian , Nick James , Angelini Pharma , Pierluigi Antonelli , Chloe Nichols , Trio Health Nina Bass , Mental Health , European Union , Sk Biopharmaceuticals Hyongki Park Head Of Communications , Angelini Pharma Daniela Poggio Head Of Communications , Committee For Medicinal Products Human Use , Sk Biopharmaceuticals Co Ltd , German Federal Institute For Drugs , Global Campaign Against Epilepsy , Drug Administration , World Health Organization , European Commission , Angelini Group , Corporate Communications , Epilepsy Alliance Europe , European Medicines Agency , Healthcare Products Regulatory Agency , Arvelle Therapeutics ,